Author

Rachel West

IMPROVED WORK PRODUCTIVITY IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH MESALAZINE IN ROUTINE CLINICAL PRACTICE IN THE NETHERLANDS: RESULTS FROM THE IMPACT STUDY
IMPROVED WORK PRODUCTIVITY IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH MESALAZINE IN ROUTINE CLINICAL PRACTICE IN THE NETHERLANDS: RESULTS FROM THE IMPACT STUDY

Rachel West  et al.

LOWER RISK OF RECURRENCE WITH A HIGHER INDUCTION DOSE OF MESALAZINE AND LONGER DURATION OF TREATMENT IN ULCERATIVE COLITIS: RESULTS FROM THE DUTCH, NON-INTERVENTIONAL, IMPACT STUDY
LOWER RISK OF RECURRENCE WITH A HIGHER INDUCTION DOSE OF MESALAZINE AND LONGER DURATION OF TREATMENT IN ULCERATIVE COLITIS: RESULTS FROM THE DUTCH, NON-INTERVENTIONAL, IMPACT STUDY

Rachel West

REAL-WORLD IMPACT OF BIOLOGICAL THERAPIES ON WORK IMPAIRMENT AND QUALITY OF LIFE IN INFLAMMATORY BOWEL DISEASE PATIENTS
REAL-WORLD IMPACT OF BIOLOGICAL THERAPIES ON WORK IMPAIRMENT AND QUALITY OF LIFE IN INFLAMMATORY BOWEL DISEASE PATIENTS

Rachel West  et al.

DE-ESCALATION OF BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASE PATIENTS FOLLOWING PRIOR ESCALATION
DE-ESCALATION OF BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASE PATIENTS FOLLOWING PRIOR ESCALATION

Rachel West  et al.

COST-EFFECTIVENESS ANALYSIS OF INCREASED ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: ECONOMIC EVALUATION OF THE RANDOMISED CONTROLLED LADI TRIAL
COST-EFFECTIVENESS ANALYSIS OF INCREASED ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: ECONOMIC EVALUATION OF THE RANDOMISED CONTROLLED LADI TRIAL

Rachel West  et al.

CLINICAL OUTCOMES OF INCREASED VERSUS CONVENTIONAL ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: THE RANDOMISED CONTROLLED LADI TRIAL
CLINICAL OUTCOMES OF INCREASED VERSUS CONVENTIONAL ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: THE RANDOMISED CONTROLLED LADI TRIAL

Rachel West  et al.

POSTOPERATIVE PROPHYLACTIC THIOPURINES OR BIOLOGICALS ARE PROTECTIVE FOR CLINICAL AND ENDOSCOPIC RECURRENCE AT SHORT TERM FOLLOW-UP AFTER PRIMARY ILEOCECAL RESECTION IN CROHN'S DISEASE, BUT NOT ASSOCIATED WITH A LONG-TERM BENEFICIAL EFFECT ON THE RISK OF
POSTOPERATIVE PROPHYLACTIC THIOPURINES OR BIOLOGICALS ARE PROTECTIVE FOR CLINICAL AND ENDOSCOPIC RECURRENCE AT SHORT TERM FOLLOW-UP AFTER PRIMARY ILEOCECAL RESECTION IN CROHN'S DISEASE, BUT NOT ASSOCIATED WITH A LONG-TERM BENEFICIAL EFFECT ON THE RISK OF

Rachel West  et al.

PREVALENCE OF IRON DEFICIENCY AND ANAEMIA IN THE OUTPATIENT INFLAMMATORY BOWEL DISEASE POPULATION: A DUTCH NATIONAL CROSS-SECTIONAL STUDY
PREVALENCE OF IRON DEFICIENCY AND ANAEMIA IN THE OUTPATIENT INFLAMMATORY BOWEL DISEASE POPULATION: A DUTCH NATIONAL CROSS-SECTIONAL STUDY

Rachel West  et al.

PREHABILITATION STRATEGIES PRIOR TO ILEOCOLIC (RE-)RESECTION IN PATIENTS WITH CROHN’S DISEASE: A MISSED WINDOW OF OPPORTUNITY?
PREHABILITATION STRATEGIES PRIOR TO ILEOCOLIC (RE-)RESECTION IN PATIENTS WITH CROHN’S DISEASE: A MISSED WINDOW OF OPPORTUNITY?

Rachel West  et al.

TIME TRENDS FOR POSTOPERATIVE RECURRENCE AFTER ILEOCECAL RESECTION IN CROHN'S DISEASE: DETAILED EVALUATION OF ASSOCIATED FACTORS
TIME TRENDS FOR POSTOPERATIVE RECURRENCE AFTER ILEOCECAL RESECTION IN CROHN'S DISEASE: DETAILED EVALUATION OF ASSOCIATED FACTORS

Rachel West  et al.

MERCAPTOPURINE TREATMENT USING THERAPEUTIC DRUG MONITORING IS EFFECTIVE IN ULCERATIVE COLITIS: A PLACEBO-CONTROLLED RANDOMIZED TRIAL
MERCAPTOPURINE TREATMENT USING THERAPEUTIC DRUG MONITORING IS EFFECTIVE IN ULCERATIVE COLITIS: A PLACEBO-CONTROLLED RANDOMIZED TRIAL

Rachel West  et al.

RISK ASSESSMENT FOR POSTOPERATIVE RECURRENCE AFTER ILEOCOLONIC RESECTION IN CROHN'S DISEASE (ON BEHALF OF THE DUTCH INITIATIVE ON CROHN AND COLITIS (ICC)
RISK ASSESSMENT FOR POSTOPERATIVE RECURRENCE AFTER ILEOCOLONIC RESECTION IN CROHN'S DISEASE (ON BEHALF OF THE DUTCH INITIATIVE ON CROHN AND COLITIS (ICC)

Rachel West  et al.

SUPERIOR EFFECTIVENESS OF TOFACITINIB COMPARED TO VEDOLIZUMAB IN ANTI-TNF EXPERIENCED ULCERATIVE COLITIS PATIENTS: A NATIONWIDE DUTCH REGISTRY STUDY
SUPERIOR EFFECTIVENESS OF TOFACITINIB COMPARED TO VEDOLIZUMAB IN ANTI-TNF EXPERIENCED ULCERATIVE COLITIS PATIENTS: A NATIONWIDE DUTCH REGISTRY STUDY

Rachel West  et al.

Item 1 - 13 / 13
1